Konstantinos Sidiropoulos, M.D., MBBS, Ph.D., MSc, HonBSc, FRCPC, FCAP (pathology)
Assistant Professor, Computational Medicine/Clinical Systems Biology Group
As a clinician scientist, Dr. Sidiropoulos’s training at leading institutions helped develop an expertise in translational clinical research with identification of novel molecular biomarkers for prognostic (diagnostic), as well as predictive (therapeutic) targets through big data (large scale computational) analysis to help patients. He has received numerous awards & scholarships and presented in many locations worldwide. As an assistant professor in the Clinical Systems Biology/Computation Medicine Group at the Institute for Neuro-Immune Medicine, he applies computational methods identifying novel diagnostic and therapeutic targets to help patients with complex illnesses.
Dr. Sidiropoulos is a medical specialist (MD pathology, US board certified FCAP) with many years helping thousands of patients as a staff diagnostic consultant and pathologist. He obtained his medical specialist degree in Laboratory Medicine and Pathology at the University of Toronto and was a resident at many world renown hospitals with training in medicine, surgery, oncology, and diagnostic medicine.
As a post-doctoral fellow, and more recently conducting cancer research, Dr. Sidiropoulos has expertise in large data set analyses (patient and molecular data) with publications in leading journals such as Molecular Oncology, Oncoscience, as well as others. He has also received numerous specializations, certifications, and training in integrative medicine as well as computational methodology for patient big data ("omic") analysis including biostatistics & bioinformatics.
Dr. Sidiropoulos completed his medical training at Sydney University, Australia. Prior to his medical training, as a doctorate (PhD) and masters (MSc) in Laboratory Medicine & Pathobiology at the University of Toronto (UofT), Dr. Sidiropoulos’s theses were in RNA function, and the relationship between endocrine-cellular signaling pathways in the molecular regulation of LDL (bad cholesterol) production with prestigious publications in Biochemistry, Diabetes, and others. Before his graduate training, Dr. Sidiropoulos received a specialist degree in Molecular Biology and Molecular Genetics (Hon.B.Sc.) from the UofT, with a major in human biology.